Nicole R Pinelli

Summary

Affiliation: Wayne State University
Country: USA

Publications

  1. ncbi Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 46:124-9. 2012
  2. ncbi Successful long-term use of sitagliptin for the treatment of new-onset diabetes mellitus after solid organ transplantation: a case report
    N R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, Michigan 48201, USA
    Transplant Proc 43:2113-5. 2011
  3. ncbi Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave, Detroit, MI 48201 2417, USA
    J Clin Pharmacol 51:165-72. 2011
  4. ncbi Incretin-based therapy in chronic kidney disease
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201 2427, USA
    Adv Chronic Kidney Dis 17:439-49. 2010
  5. ncbi Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 45:850-60. 2011
  6. ncbi Family support is associated with success in achieving weight loss in a group lifestyle intervention for diabetes prevention in Arab Americans
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201 2417, USA
    Ethn Dis 21:480-4. 2011
  7. ncbi Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201 2417, USA
    Diabetes Res Clin Pract 90:e27-9. 2010
  8. ncbi Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans
    Linda A Jaber
    Department of Pharmacy Practice, Wayne State University, MI, USA
    Diabetes Res Clin Pract 91:307-15. 2011
  9. ncbi Practices of Arab American patients with type 2 diabetes mellitus during Ramadan
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI, USA
    J Pharm Pract 24:211-5. 2011
  10. ncbi Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201, USA
    Ann Pharmacother 42:1541-51. 2008

Detail Information

Publications15

  1. ncbi Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 46:124-9. 2012
    ..To review literature evaluating the safety and efficacy of exogenous glucagon-like peptide-1 (GLP-1) for hyperglycemia in critically ill patients...
  2. ncbi Successful long-term use of sitagliptin for the treatment of new-onset diabetes mellitus after solid organ transplantation: a case report
    N R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, Michigan 48201, USA
    Transplant Proc 43:2113-5. 2011
    ..To describe 2.5 years of exposure to sitagliptin on glycemic control, immunosuppressive therapy, and adverse events following solid organ transplantation...
  3. ncbi Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave, Detroit, MI 48201 2417, USA
    J Clin Pharmacol 51:165-72. 2011
    ..Postprandial glucose concentrations and the frequency of adverse events did not differ by the administration time of exenatide...
  4. ncbi Incretin-based therapy in chronic kidney disease
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201 2427, USA
    Adv Chronic Kidney Dis 17:439-49. 2010
    ..This review will discuss the literature examining the efficacy and safety of incretin-based therapies in T2DM and the available evidence for their use in CKD...
  5. ncbi Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 45:850-60. 2011
    ..Long-acting glucagon-like peptide-1 receptor agonists (LA-GLP-1RAs) may deliver additional therapeutic benefits over other available incretin-based therapies...
  6. ncbi Family support is associated with success in achieving weight loss in a group lifestyle intervention for diabetes prevention in Arab Americans
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201 2417, USA
    Ethn Dis 21:480-4. 2011
    ..The objective of this study was to examine factors associated with weight-loss goal attainment at 24-weeks of the lifestyle intervention...
  7. ncbi Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201 2417, USA
    Diabetes Res Clin Pract 90:e27-9. 2010
    ..These findings imply that educational interventions communicating risk may improve adoption of diabetes preventative efforts...
  8. ncbi Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans
    Linda A Jaber
    Department of Pharmacy Practice, Wayne State University, MI, USA
    Diabetes Res Clin Pract 91:307-15. 2011
    ..To assess the feasibility and acceptability of a community-based, culturally-specific, Diabetes Prevention Program (DPP)-adapted, group lifestyle intervention in Arab-Americans...
  9. ncbi Practices of Arab American patients with type 2 diabetes mellitus during Ramadan
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI, USA
    J Pharm Pract 24:211-5. 2011
    ..To examine practices and complications among Arab Americans observing fasting during Ramadan...
  10. ncbi Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201, USA
    Ann Pharmacother 42:1541-51. 2008
    ..The introduction of several new therapeutic agents for the treatment of type 2 diabetes mellitus has led to significant challenges for providers in deciding which agent to select during the disease course...
  11. ncbi Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201 2417, USA
    J Clin Endocrinol Metab 96:E1680-3. 2011
    ..The diagnostic utility of A1C has not been evaluated in Arabs, a population at increased risk for developing diabetes...
  12. ncbi Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, Michigan, USA
    Diabetes Care 33:1373-5. 2010
    ..To describe 25-hydroxy vitamin D (25-OH-D) levels and examine associations between 25-OH-D levels and insulin resistance (IR), metabolic syndrome (MS), and glucose intolerance in Arab Americans...
  13. ncbi Drug-drug interactions with glucagon-like peptide-1 receptor agonists
    Kathryn M Hurren
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 46:710-7. 2012
    ..To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications...
  14. ncbi Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
    Helen Berlie
    Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Diabetes Metab Syndr Obes 5:165-74. 2012
    ..This review demonstrates that adding a GLP-1RA to an existing basal insulin regimen is a reasonable treatment strategy in nonpregnant adult patients with T2DM...
  15. ncbi Risk perception for developing diabetes among pharmacists
    Nicole R Pinelli
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Ann Pharmacother 43:1050-6. 2009
    ..Emerging evidence implies that differences in risk perception between healthcare professionals and the lay public exist...